

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | porphyrin-containing compound metabolic process (GO:0006778) | 9.45674935 |
| 2 | heme metabolic process (GO:0042168) | 9.36116217 |
| 3 | erythrocyte maturation (GO:0043249) | 8.47471329 |
| 4 | erythrocyte development (GO:0048821) | 7.44363111 |
| 5 | response to methylmercury (GO:0051597) | 6.92961355 |
| 6 | hemoglobin metabolic process (GO:0020027) | 6.70680629 |
| 7 | tetrapyrrole metabolic process (GO:0033013) | 6.33947237 |
| 8 | one-carbon compound transport (GO:0019755) | 6.29354381 |
| 9 | response to insecticide (GO:0017085) | 5.62633861 |
| 10 | response to lead ion (GO:0010288) | 5.49951029 |
| 11 | bicarbonate transport (GO:0015701) | 5.28346848 |
| 12 | pigment biosynthetic process (GO:0046148) | 5.22813524 |
| 13 | myeloid cell development (GO:0061515) | 4.83885585 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.77730719 |
| 15 | regulation of response to osmotic stress (GO:0047484) | 4.76701870 |
| 16 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.71214586 |
| 17 | erythrocyte differentiation (GO:0030218) | 4.66538219 |
| 18 | pigment metabolic process (GO:0042440) | 4.53646902 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.49417423 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.33012736 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.26276799 |
| 22 | response to peptidoglycan (GO:0032494) | 4.17606289 |
| 23 | type I interferon signaling pathway (GO:0060337) | 4.13709290 |
| 24 | cellular response to type I interferon (GO:0071357) | 4.13709290 |
| 25 | response to type I interferon (GO:0034340) | 4.08503875 |
| 26 | gas transport (GO:0015669) | 4.08240274 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 4.06778319 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 4.06778319 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.06778319 |
| 30 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.06778319 |
| 31 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.06778319 |
| 32 | modulation by symbiont of host immune response (GO:0052553) | 4.06778319 |
| 33 | granulocyte differentiation (GO:0030851) | 4.02622889 |
| 34 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.98273558 |
| 35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.95815829 |
| 36 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.93736825 |
| 37 | B cell mediated immunity (GO:0019724) | 3.93017747 |
| 38 | T-helper 1 type immune response (GO:0042088) | 3.90220108 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 3.88174911 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.86920446 |
| 41 | myeloid dendritic cell differentiation (GO:0043011) | 3.85649325 |
| 42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.68071537 |
| 43 | regulation of interferon-alpha production (GO:0032647) | 3.64837086 |
| 44 | embryonic hemopoiesis (GO:0035162) | 3.62171099 |
| 45 | positive regulation of type 2 immune response (GO:0002830) | 3.61670269 |
| 46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.55021330 |
| 47 | myeloid dendritic cell activation (GO:0001773) | 3.53078888 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52886289 |
| 49 | negative regulation of cell killing (GO:0031342) | 3.52886289 |
| 50 | defense response to protozoan (GO:0042832) | 3.43742422 |
| 51 | germinal center formation (GO:0002467) | 3.42984987 |
| 52 | regulation of antigen processing and presentation (GO:0002577) | 3.42745626 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.38123054 |
| 54 | iron ion import (GO:0097286) | 3.35951205 |
| 55 | positive regulation of interferon-alpha production (GO:0032727) | 3.34012515 |
| 56 | positive regulation of antigen processing and presentation (GO:0002579) | 3.33830393 |
| 57 | response to protozoan (GO:0001562) | 3.31932155 |
| 58 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.30303479 |
| 59 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.27223687 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.22615519 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.21751912 |
| 62 | dendritic cell differentiation (GO:0097028) | 3.21420342 |
| 63 | T cell migration (GO:0072678) | 3.20083463 |
| 64 | protein-cofactor linkage (GO:0018065) | 3.19785000 |
| 65 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.18127723 |
| 66 | platelet formation (GO:0030220) | 3.17798367 |
| 67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17626513 |
| 68 | detection of bacterium (GO:0016045) | 3.17606211 |
| 69 | detection of other organism (GO:0098543) | 3.17428461 |
| 70 | cellular response to interferon-gamma (GO:0071346) | 3.16730328 |
| 71 | positive regulation of B cell mediated immunity (GO:0002714) | 3.16074753 |
| 72 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.16074753 |
| 73 | regulation of podosome assembly (GO:0071801) | 3.15173148 |
| 74 | regulation of interleukin-12 production (GO:0032655) | 3.13911959 |
| 75 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.13113739 |
| 76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.12422236 |
| 77 | megakaryocyte development (GO:0035855) | 3.12373404 |
| 78 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.11372461 |
| 79 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.10040515 |
| 80 | positive regulation of mast cell activation (GO:0033005) | 3.09974593 |
| 81 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.09257678 |
| 82 | cofactor biosynthetic process (GO:0051188) | 3.08766210 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05440663 |
| 84 | response to arsenic-containing substance (GO:0046685) | 3.04398801 |
| 85 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.03947499 |
| 86 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.02548548 |
| 87 | iron ion homeostasis (GO:0055072) | 3.01650655 |
| 88 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.01495047 |
| 89 | adenosine receptor signaling pathway (GO:0001973) | 3.01207078 |
| 90 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00151907 |
| 91 | regulation of chronic inflammatory response (GO:0002676) | 2.98211186 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 2.98118094 |
| 93 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.97390929 |
| 94 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.97190303 |
| 95 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96844820 |
| 96 | response to host immune response (GO:0052572) | 2.96844820 |
| 97 | granulocyte activation (GO:0036230) | 2.96675931 |
| 98 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.95747432 |
| 99 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.95559882 |
| 100 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.95286850 |
| 101 | B cell receptor signaling pathway (GO:0050853) | 2.95111295 |
| 102 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.94324709 |
| 103 | regulation of T-helper cell differentiation (GO:0045622) | 2.93696841 |
| 104 | response to interferon-gamma (GO:0034341) | 2.93274273 |
| 105 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.93053699 |
| 106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90172202 |
| 107 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.90063434 |
| 108 | positive regulation of interleukin-12 production (GO:0032735) | 2.88760916 |
| 109 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.87772732 |
| 110 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.86967929 |
| 111 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.86398133 |
| 112 | regulation of mast cell degranulation (GO:0043304) | 2.83653690 |
| 113 | positive regulation of interleukin-10 production (GO:0032733) | 2.82642532 |
| 114 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.82383325 |
| 115 | DNA replication checkpoint (GO:0000076) | 2.81821742 |
| 116 | kinetochore assembly (GO:0051382) | 2.80890752 |
| 117 | regulation of DNA endoreduplication (GO:0032875) | 2.79931602 |
| 118 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.79649392 |
| 119 | activation of MAPKKK activity (GO:0000185) | 2.79353946 |
| 120 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.78701629 |
| 121 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.78686157 |
| 122 | regulation of mononuclear cell migration (GO:0071675) | 2.77994372 |
| 123 | B cell proliferation (GO:0042100) | 2.77543969 |
| 124 | plasma lipoprotein particle assembly (GO:0034377) | 2.77202482 |
| 125 | actin filament capping (GO:0051693) | 2.76751409 |
| 126 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.76750898 |
| 127 | regulation of erythrocyte differentiation (GO:0045646) | 2.76586577 |
| 128 | kinetochore organization (GO:0051383) | 2.76515363 |
| 129 | centriole assembly (GO:0098534) | 2.72774051 |
| 130 | regulation of type 2 immune response (GO:0002828) | 2.72506041 |
| 131 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.72305553 |
| 132 | positive regulation of B cell differentiation (GO:0045579) | 2.72112680 |
| 133 | detection of external biotic stimulus (GO:0098581) | 2.71979797 |
| 134 | N-acetylneuraminate metabolic process (GO:0006054) | 2.71205810 |
| 135 | neutrophil activation (GO:0042119) | 2.69280096 |
| 136 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.69075064 |
| 137 | response to thyroid hormone (GO:0097066) | 2.69036847 |
| 138 | energy homeostasis (GO:0097009) | 2.68455481 |
| 139 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.68290402 |
| 140 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.67016510 |
| 141 | cysteine metabolic process (GO:0006534) | 2.66379030 |
| 142 | regulation of immunoglobulin secretion (GO:0051023) | 2.64462438 |
| 143 | regulation of hypersensitivity (GO:0002883) | 2.62840805 |
| 144 | import into cell (GO:0098657) | 2.62218487 |
| 145 | negative regulation of viral entry into host cell (GO:0046597) | 2.60285705 |
| 146 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.59982929 |
| 147 | receptor recycling (GO:0001881) | 2.59817809 |
| 148 | protein autoprocessing (GO:0016540) | 2.59203485 |
| 149 | NAD biosynthetic process (GO:0009435) | 2.58626227 |
| 150 | indole-containing compound catabolic process (GO:0042436) | 2.57132028 |
| 151 | indolalkylamine catabolic process (GO:0046218) | 2.57132028 |
| 152 | tryptophan catabolic process (GO:0006569) | 2.57132028 |
| 153 | microtubule depolymerization (GO:0007019) | 2.55879518 |
| 154 | drug transmembrane transport (GO:0006855) | 2.55681937 |
| 155 | meiotic chromosome segregation (GO:0045132) | 2.55515489 |
| 156 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.52358788 |
| 157 | superoxide anion generation (GO:0042554) | 2.52317180 |
| 158 | cellular biogenic amine catabolic process (GO:0042402) | 2.52074013 |
| 159 | amine catabolic process (GO:0009310) | 2.52074013 |
| 160 | innate immune response in mucosa (GO:0002227) | 2.49948569 |
| 161 | metallo-sulfur cluster assembly (GO:0031163) | 2.49788410 |
| 162 | iron-sulfur cluster assembly (GO:0016226) | 2.49788410 |
| 163 | regulation of RIG-I signaling pathway (GO:0039535) | 2.49157947 |
| 164 | cellular response to dexamethasone stimulus (GO:0071549) | 2.48129794 |
| 165 | DNA synthesis involved in DNA repair (GO:0000731) | 2.45056216 |
| 166 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.42250652 |
| 167 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.41073369 |
| 168 | proteasome assembly (GO:0043248) | 2.38630239 |
| 169 | transition metal ion homeostasis (GO:0055076) | 2.34708734 |
| 170 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.34255784 |
| 171 | protein K6-linked ubiquitination (GO:0085020) | 2.33448721 |
| 172 | lipoxygenase pathway (GO:0019372) | 2.32502768 |
| 173 | lysine catabolic process (GO:0006554) | 2.32177792 |
| 174 | lysine metabolic process (GO:0006553) | 2.32177792 |
| 175 | motile cilium assembly (GO:0044458) | 2.30783734 |
| 176 | DNA replication initiation (GO:0006270) | 2.30751840 |
| 177 | response to dexamethasone (GO:0071548) | 2.30237187 |
| 178 | tryptophan metabolic process (GO:0006568) | 2.30007380 |
| 179 | regulation of activation of Janus kinase activity (GO:0010533) | 2.29550640 |
| 180 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.29127517 |
| 181 | nucleosome assembly (GO:0006334) | 2.28584859 |
| 182 | heme transport (GO:0015886) | 2.28062088 |
| 183 | response to xenobiotic stimulus (GO:0009410) | 2.27452059 |
| 184 | mitotic sister chromatid segregation (GO:0000070) | 2.24663144 |
| 185 | drug transport (GO:0015893) | 2.24109583 |
| 186 | hydrogen peroxide catabolic process (GO:0042744) | 2.22628214 |
| 187 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.21726206 |
| 188 | protein-lipid complex assembly (GO:0065005) | 2.20222884 |
| 189 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.20219543 |
| 190 | response to oxygen radical (GO:0000305) | 2.20096982 |
| 191 | organic cation transport (GO:0015695) | 2.18840114 |
| 192 | antibacterial humoral response (GO:0019731) | 2.17198674 |
| 193 | protoporphyrinogen IX metabolic process (GO:0046501) | 16.9247049 |
| 194 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 15.6636190 |
| 195 | porphyrin-containing compound biosynthetic process (GO:0006779) | 11.8299508 |
| 196 | heme biosynthetic process (GO:0006783) | 11.6807578 |
| 197 | tetrapyrrole biosynthetic process (GO:0033014) | 10.7698474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.78948451 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.65259991 |
| 3 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 4.99073907 |
| 4 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 4.68332195 |
| 5 | * GATA1_19941826_ChIP-Seq_K562_Human | 4.50540621 |
| 6 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.40482349 |
| 7 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 4.40146057 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.63386107 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.55962404 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.07771983 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.94001785 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.91190042 |
| 13 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.87056969 |
| 14 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.82013027 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.76403478 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.67738981 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67556370 |
| 18 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.59038506 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55475567 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.44351159 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35886903 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.30333571 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.28497207 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.25189444 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.25143588 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.18856705 |
| 27 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.18823756 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.13222789 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.09068340 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08353618 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 2.07312931 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.05842364 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02795063 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.99928802 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99840247 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97487469 |
| 37 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.92411319 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.91126573 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79182406 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77970604 |
| 41 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.69802148 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.68147948 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65441992 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.64104547 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.62255257 |
| 46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61635388 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.61337944 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60477517 |
| 49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57199223 |
| 50 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.52590661 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52417045 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.52284912 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50168408 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.49620337 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48342839 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46447993 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44696673 |
| 58 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.43217900 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42848817 |
| 60 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.42848270 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.42540232 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41422803 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39650261 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36748721 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36522571 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35607092 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35198566 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32960995 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32124893 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30331337 |
| 71 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30297030 |
| 72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30027782 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28657562 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27941812 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24405484 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24175622 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20811038 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20698051 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20489562 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20475102 |
| 81 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.18407720 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17832281 |
| 83 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16170858 |
| 84 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15758501 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14975930 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14796261 |
| 87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13406908 |
| 88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12476737 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12136080 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11602036 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09289923 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.09066903 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08436721 |
| 94 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.07233377 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06674857 |
| 96 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.06441503 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05894975 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05440059 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04557850 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03788947 |
| 101 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03626892 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03587905 |
| 103 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99767947 |
| 104 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99286833 |
| 105 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99176278 |
| 106 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98328384 |
| 107 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95802631 |
| 108 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.94032476 |
| 109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93350544 |
| 110 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.93156548 |
| 111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.92160557 |
| 112 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91376716 |
| 113 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88942427 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87384224 |
| 115 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86810888 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85944343 |
| 117 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85248685 |
| 118 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84357284 |
| 119 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84206435 |
| 120 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.83969481 |
| 121 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80697344 |
| 122 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.80401338 |
| 123 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.80300296 |
| 124 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79541292 |
| 125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.78876679 |
| 126 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.77901998 |
| 127 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77037237 |
| 128 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.76723814 |
| 129 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76206914 |
| 130 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.75980405 |
| 131 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73969865 |
| 132 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.73728884 |
| 133 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.72270008 |
| 134 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.72210103 |
| 135 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.71857309 |
| 136 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71677045 |
| 137 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.71329043 |
| 138 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.70360021 |
| 139 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70232480 |
| 140 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.69127758 |
| 141 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.68986804 |
| 142 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.68853856 |
| 143 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.68198844 |
| 144 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.68152361 |
| 145 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.67949476 |
| 146 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.67719918 |
| 147 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.66214007 |
| 148 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.65887863 |
| 149 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.65810446 |
| 150 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.65281798 |
| 151 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.65044549 |
| 152 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.64379064 |
| 153 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.63581013 |
| 154 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.63179227 |
| 155 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.62913556 |
| 156 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62701374 |
| 157 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.62318001 |
| 158 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.62029923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 9.46289656 |
| 2 | MP0004147_increased_porphyrin_level | 8.75708024 |
| 3 | MP0003303_peritoneal_inflammation | 5.08040637 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 3.53441157 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.13206788 |
| 6 | MP0004510_myositis | 3.03819266 |
| 7 | MP0003724_increased_susceptibility_to | 2.94121659 |
| 8 | MP0006082_CNS_inflammation | 2.58379563 |
| 9 | MP0005083_abnormal_biliary_tract | 2.53853030 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.52299322 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.47272161 |
| 12 | MP0008004_abnormal_stomach_pH | 2.47227436 |
| 13 | MP0005636_abnormal_mineral_homeostasis | 2.44648242 |
| 14 | MP0009840_abnormal_foam_cell | 2.33739738 |
| 15 | MP0003111_abnormal_nucleus_morphology | 2.24731775 |
| 16 | MP0001545_abnormal_hematopoietic_system | 2.12720864 |
| 17 | MP0005397_hematopoietic_system_phenotyp | 2.12720864 |
| 18 | MP0010155_abnormal_intestine_physiology | 1.95253511 |
| 19 | MP0005451_abnormal_body_composition | 1.88708882 |
| 20 | MP0000343_altered_response_to | 1.87475368 |
| 21 | MP0001845_abnormal_inflammatory_respons | 1.84196100 |
| 22 | MP0004947_skin_inflammation | 1.82144765 |
| 23 | MP0003075_altered_response_to | 1.80163599 |
| 24 | MP0002132_abnormal_respiratory_system | 1.77170212 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.72172939 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.68886749 |
| 27 | MP0009764_decreased_sensitivity_to | 1.64936933 |
| 28 | MP0003186_abnormal_redox_activity | 1.64229630 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.63349773 |
| 30 | MP0005310_abnormal_salivary_gland | 1.62056369 |
| 31 | MP0008057_abnormal_DNA_replication | 1.56752754 |
| 32 | MP0009278_abnormal_bone_marrow | 1.53584430 |
| 33 | MP0002405_respiratory_system_inflammati | 1.53524282 |
| 34 | MP0008872_abnormal_physiological_respon | 1.51536375 |
| 35 | MP0000685_abnormal_immune_system | 1.50146228 |
| 36 | MP0008260_abnormal_autophagy | 1.48080207 |
| 37 | MP0010094_abnormal_chromosome_stability | 1.47156513 |
| 38 | MP0004043_abnormal_pH_regulation | 1.45363373 |
| 39 | MP0002254_reproductive_system_inflammat | 1.42752494 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.42073866 |
| 41 | MP0006292_abnormal_olfactory_placode | 1.41461130 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.41323174 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.39079338 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.37664132 |
| 45 | MP0005379_endocrine/exocrine_gland_phen | 1.36866768 |
| 46 | MP0000858_altered_metastatic_potential | 1.35005921 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.34361075 |
| 48 | MP0002163_abnormal_gland_morphology | 1.34052410 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.34010686 |
| 50 | MP0008058_abnormal_DNA_repair | 1.34007006 |
| 51 | MP0005671_abnormal_response_to | 1.31946351 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.27632704 |
| 53 | MP0000604_amyloidosis | 1.27055348 |
| 54 | MP0002736_abnormal_nociception_after | 1.24505760 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.22915021 |
| 56 | MP0005085_abnormal_gallbladder_physiolo | 1.20604922 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.20238104 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.19355852 |
| 59 | * MP0002398_abnormal_bone_marrow | 1.18900817 |
| 60 | MP0005166_decreased_susceptibility_to | 1.12463193 |
| 61 | MP0005360_urolithiasis | 1.12097961 |
| 62 | MP0003195_calcinosis | 1.10925020 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.09541012 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.09439712 |
| 65 | MP0001188_hyperpigmentation | 1.08730136 |
| 66 | MP0001764_abnormal_homeostasis | 1.08540222 |
| 67 | MP0001968_abnormal_touch/_nociception | 1.08193172 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.08171459 |
| 69 | MP0002735_abnormal_chemical_nociception | 1.08081000 |
| 70 | MP0003787_abnormal_imprinting | 1.06287384 |
| 71 | MP0003448_altered_tumor_morphology | 1.06192173 |
| 72 | MP0001790_abnormal_immune_system | 1.05286020 |
| 73 | MP0005387_immune_system_phenotype | 1.05286020 |
| 74 | MP0000490_abnormal_crypts_of | 1.03876802 |
| 75 | MP0009643_abnormal_urine_homeostasis | 1.00880816 |
| 76 | MP0001765_abnormal_ion_homeostasis | 1.00124981 |
| 77 | MP0003077_abnormal_cell_cycle | 0.99759537 |
| 78 | MP0001663_abnormal_digestive_system | 0.98808149 |
| 79 | * MP0000689_abnormal_spleen_morphology | 0.95565167 |
| 80 | MP0008874_decreased_physiological_sensi | 0.95354153 |
| 81 | MP0009785_altered_susceptibility_to | 0.95301671 |
| 82 | MP0003091_abnormal_cell_migration | 0.94353790 |
| 83 | MP0003690_abnormal_glial_cell | 0.94214384 |
| 84 | * MP0002429_abnormal_blood_cell | 0.92834036 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.92411057 |
| 86 | * MP0002722_abnormal_immune_system | 0.91270855 |
| 87 | MP0005025_abnormal_response_to | 0.89097464 |
| 88 | MP0002396_abnormal_hematopoietic_system | 0.88595643 |
| 89 | MP0005535_abnormal_body_temperature | 0.86763702 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 0.85474397 |
| 91 | MP0003693_abnormal_embryo_hatching | 0.84377676 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.82670016 |
| 93 | MP0003011_delayed_dark_adaptation | 0.81065587 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.80619439 |
| 95 | MP0008469_abnormal_protein_level | 0.80262695 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.79955454 |
| 97 | MP0004859_abnormal_synaptic_plasticity | 0.79817225 |
| 98 | MP0000703_abnormal_thymus_morphology | 0.79191729 |
| 99 | MP0001851_eye_inflammation | 0.76462542 |
| 100 | MP0005000_abnormal_immune_tolerance | 0.76112565 |
| 101 | MP0005332_abnormal_amino_acid | 0.75920554 |
| 102 | MP0005165_increased_susceptibility_to | 0.75528053 |
| 103 | MP0000249_abnormal_blood_vessel | 0.75311756 |
| 104 | MP0001346_abnormal_lacrimal_gland | 0.74839893 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.74591558 |
| 106 | MP0001756_abnormal_urination | 0.74565935 |
| 107 | MP0004808_abnormal_hematopoietic_stem | 0.74560560 |
| 108 | MP0003252_abnormal_bile_duct | 0.73959969 |
| 109 | MP0001873_stomach_inflammation | 0.73856780 |
| 110 | MP0003879_abnormal_hair_cell | 0.72995839 |
| 111 | MP0002419_abnormal_innate_immunity | 0.72170031 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.71615947 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.70608623 |
| 114 | MP0003191_abnormal_cellular_cholesterol | 0.70249628 |
| 115 | MP0009745_abnormal_behavioral_response | 0.69545386 |
| 116 | MP0008877_abnormal_DNA_methylation | 0.69105329 |
| 117 | MP0003718_maternal_effect | 0.66359015 |
| 118 | MP0005174_abnormal_tail_pigmentation | 0.66348555 |
| 119 | MP0003786_premature_aging | 0.65474344 |
| 120 | MP0001529_abnormal_vocalization | 0.65367753 |
| 121 | MP0000313_abnormal_cell_death | 0.64654434 |
| 122 | MP0001819_abnormal_immune_cell | 0.64339599 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.64235318 |
| 124 | MP0002723_abnormal_immune_serum | 0.62990842 |
| 125 | MP0002928_abnormal_bile_duct | 0.62523030 |
| 126 | * MP0000716_abnormal_immune_system | 0.62392749 |
| 127 | MP0005365_abnormal_bile_salt | 0.61972867 |
| 128 | MP0003436_decreased_susceptibility_to | 0.61778596 |
| 129 | MP0002420_abnormal_adaptive_immunity | 0.61642772 |
| 130 | MP0001853_heart_inflammation | 0.60841329 |
| 131 | MP0005647_abnormal_sex_gland | 0.60170593 |
| 132 | MP0000920_abnormal_myelination | 0.59994346 |
| 133 | MP0000609_abnormal_liver_physiology | 0.59744552 |
| 134 | MP0003866_abnormal_defecation | 0.59505607 |
| 135 | MP0003795_abnormal_bone_structure | 0.59299956 |
| 136 | MP0009763_increased_sensitivity_to | 0.59170253 |
| 137 | MP0002452_abnormal_antigen_presenting | 0.59019501 |
| 138 | MP0008995_early_reproductive_senescence | 0.58350633 |
| 139 | MP0005381_digestive/alimentary_phenotyp | 0.58100996 |
| 140 | MP0002166_altered_tumor_susceptibility | 0.57811520 |
| 141 | MP0009931_abnormal_skin_appearance | 0.56869918 |
| 142 | MP0003828_pulmonary_edema | 0.56647413 |
| 143 | MP0003172_abnormal_lysosome_physiology | 0.56426309 |
| 144 | MP0005666_abnormal_adipose_tissue | 0.56222259 |
| 145 | MP0000566_synostosis | 0.56156328 |
| 146 | MP0005390_skeleton_phenotype | 0.56009832 |
| 147 | MP0004142_abnormal_muscle_tone | 0.54838853 |
| 148 | MP0003880_abnormal_central_pattern | 0.54231772 |
| 149 | MP0001800_abnormal_humoral_immune | 0.53766136 |
| 150 | MP0008775_abnormal_heart_ventricle | 0.52071224 |
| 151 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52062718 |
| 152 | MP0005319_abnormal_enzyme/_coenzyme | 0.49835362 |
| 153 | MP0004883_abnormal_blood_vessel | 0.46692281 |
| 154 | MP0009642_abnormal_blood_homeostasis | 0.46166664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acanthocytosis (HP:0001927) | 7.54505649 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 7.16582826 |
| 3 | Reticulocytosis (HP:0001923) | 6.43731772 |
| 4 | Osteomalacia (HP:0002749) | 5.38538117 |
| 5 | Cholelithiasis (HP:0001081) | 4.89680196 |
| 6 | Diaphragmatic weakness (HP:0009113) | 4.87060876 |
| 7 | Hyperbilirubinemia (HP:0002904) | 4.81102581 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.68019005 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.67745081 |
| 10 | Paralysis (HP:0003470) | 4.66657564 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.65581037 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.65581037 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.65581037 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 4.58045838 |
| 15 | Abnormality of reticulocytes (HP:0004312) | 4.54531298 |
| 16 | Abnormal gallbladder morphology (HP:0012437) | 4.50874438 |
| 17 | Hypochromic anemia (HP:0001931) | 4.02494212 |
| 18 | Gastrointestinal stroma tumor (HP:0100723) | 3.97280978 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.93743359 |
| 20 | Dysostosis multiplex (HP:0000943) | 3.65278510 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.62062939 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.61320871 |
| 23 | Cutaneous photosensitivity (HP:0000992) | 3.58175422 |
| 24 | Petechiae (HP:0000967) | 3.50115874 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.47769397 |
| 26 | Microcytic anemia (HP:0001935) | 3.47417932 |
| 27 | Optic neuritis (HP:0100653) | 3.43914390 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.43914390 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 3.42202378 |
| 30 | Orchitis (HP:0100796) | 3.31641570 |
| 31 | Vasculitis (HP:0002633) | 3.31467295 |
| 32 | Cholecystitis (HP:0001082) | 3.27616006 |
| 33 | Abnormal gallbladder physiology (HP:0012438) | 3.27616006 |
| 34 | Menorrhagia (HP:0000132) | 3.26018514 |
| 35 | Abnormal platelet volume (HP:0011876) | 3.25325998 |
| 36 | Meningitis (HP:0001287) | 3.22135756 |
| 37 | Insomnia (HP:0100785) | 3.22083013 |
| 38 | Stomatitis (HP:0010280) | 3.20213328 |
| 39 | Abnormality of the gallbladder (HP:0005264) | 3.17638780 |
| 40 | Loss of speech (HP:0002371) | 3.16653546 |
| 41 | Disinhibition (HP:0000734) | 3.14519263 |
| 42 | Recurrent viral infections (HP:0004429) | 3.13995291 |
| 43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.13250355 |
| 44 | Abnormal number of erythroid precursors (HP:0012131) | 3.12446618 |
| 45 | Gingival bleeding (HP:0000225) | 3.11948530 |
| 46 | Increased mean platelet volume (HP:0011877) | 3.10046862 |
| 47 | IgA deficiency (HP:0002720) | 3.06469431 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 3.06077321 |
| 49 | Obstructive lung disease (HP:0006536) | 3.06077321 |
| 50 | Hyponatremia (HP:0002902) | 3.03857619 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.97210828 |
| 52 | Myositis (HP:0100614) | 2.97060566 |
| 53 | Glomerulonephritis (HP:0000099) | 2.93675935 |
| 54 | Polycythemia (HP:0001901) | 2.92349238 |
| 55 | Colitis (HP:0002583) | 2.90522222 |
| 56 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.87742409 |
| 57 | Chromsome breakage (HP:0040012) | 2.81240908 |
| 58 | Recurrent skin infections (HP:0001581) | 2.79583473 |
| 59 | Abnormality of sodium homeostasis (HP:0010931) | 2.76112324 |
| 60 | Short middle phalanx of the 5th finger (HP:0004220) | 2.71884609 |
| 61 | Recurrent fungal infections (HP:0002841) | 2.70912527 |
| 62 | Renal tubular acidosis (HP:0001947) | 2.69514997 |
| 63 | Encephalitis (HP:0002383) | 2.68981847 |
| 64 | Recurrent sinusitis (HP:0011108) | 2.62016426 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.60712499 |
| 66 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.60129139 |
| 67 | Agammaglobulinemia (HP:0004432) | 2.59016816 |
| 68 | Inflammation of the large intestine (HP:0002037) | 2.59005979 |
| 69 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57873668 |
| 70 | Confusion (HP:0001289) | 2.56497107 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.55211746 |
| 72 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.53993101 |
| 73 | Lymphopenia (HP:0001888) | 2.53097514 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.51872630 |
| 75 | Increased serum ferritin (HP:0003281) | 2.46364932 |
| 76 | Cellulitis (HP:0100658) | 2.42656497 |
| 77 | Mutism (HP:0002300) | 2.41267345 |
| 78 | Emphysema (HP:0002097) | 2.39753749 |
| 79 | Restrictive lung disease (HP:0002091) | 2.38594349 |
| 80 | Hepatocellular carcinoma (HP:0001402) | 2.38328925 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.34035054 |
| 82 | Birth length less than 3rd percentile (HP:0003561) | 2.33917261 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33797193 |
| 84 | Nuclear cataract (HP:0100018) | 2.31939475 |
| 85 | Increased IgE level (HP:0003212) | 2.30509829 |
| 86 | Basal ganglia calcification (HP:0002135) | 2.29645087 |
| 87 | Axonal loss (HP:0003447) | 2.28645498 |
| 88 | Lower limb hyperreflexia (HP:0002395) | 2.28217138 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.27656736 |
| 90 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27461114 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27461114 |
| 92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27461114 |
| 93 | Nausea (HP:0002018) | 2.24253490 |
| 94 | Abnormality of lateral ventricle (HP:0030047) | 2.23182263 |
| 95 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23071252 |
| 96 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23071252 |
| 97 | Joint swelling (HP:0001386) | 2.22670966 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 2.22395187 |
| 99 | Complement deficiency (HP:0004431) | 2.22372620 |
| 100 | Ileus (HP:0002595) | 2.22053338 |
| 101 | Arterial thrombosis (HP:0004420) | 2.21655810 |
| 102 | Abnormality of dental color (HP:0011073) | 2.20504880 |
| 103 | Autoimmune hemolytic anemia (HP:0001890) | 2.18409651 |
| 104 | Gangrene (HP:0100758) | 2.17899264 |
| 105 | Arthralgia (HP:0002829) | 2.16781121 |
| 106 | Metabolic alkalosis (HP:0200114) | 2.16780059 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16570910 |
| 108 | Mucopolysacchariduria (HP:0008155) | 2.16570910 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 2.14381818 |
| 110 | Hemoptysis (HP:0002105) | 2.14189312 |
| 111 | Renal tubular dysfunction (HP:0000124) | 2.13210367 |
| 112 | Premature loss of primary teeth (HP:0006323) | 2.11072150 |
| 113 | Gingivitis (HP:0000230) | 2.10522934 |
| 114 | Urticaria (HP:0001025) | 2.10345274 |
| 115 | Hyperlipoproteinemia (HP:0010980) | 2.09587458 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09525515 |
| 117 | Epistaxis (HP:0000421) | 2.07814670 |
| 118 | Chronic otitis media (HP:0000389) | 2.07582456 |
| 119 | Keratoconjunctivitis (HP:0001096) | 2.06363726 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 2.05706099 |
| 121 | Cerebral palsy (HP:0100021) | 2.05694313 |
| 122 | IgM deficiency (HP:0002850) | 2.05408574 |
| 123 | Recurrent bronchitis (HP:0002837) | 2.04938600 |
| 124 | Panhypogammaglobulinemia (HP:0003139) | 2.04698322 |
| 125 | Recurrent pneumonia (HP:0006532) | 2.04522999 |
| 126 | Progressive neurologic deterioration (HP:0002344) | 2.03082019 |
| 127 | Pulmonary embolism (HP:0002204) | 2.02337569 |
| 128 | Polyneuropathy (HP:0001271) | 2.02025253 |
| 129 | Azoospermia (HP:0000027) | 2.01057794 |
| 130 | Conjunctival telangiectasia (HP:0000524) | 2.00134092 |
| 131 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 12.8725128 |
| 132 | Poikilocytosis (HP:0004447) | 10.3902288 |
| 133 | Abnormality of magnesium homeostasis (HP:0004921) | 1.98553379 |
| 134 | Hypomagnesemia (HP:0002917) | 1.98174642 |
| 135 | Hyperactive renin-angiotensin system (HP:0000841) | 1.93110768 |
| 136 | Abnormality of chloride homeostasis (HP:0011422) | 1.90946632 |
| 137 | Abnormal hair whorl (HP:0010721) | 1.90040394 |
| 138 | Rickets (HP:0002748) | 1.88450051 |
| 139 | Febrile seizures (HP:0002373) | 1.88034193 |
| 140 | Abnormality of renal excretion (HP:0011036) | 1.87825670 |
| 141 | Onycholysis (HP:0001806) | 1.87057042 |
| 142 | Pathologic fracture (HP:0002756) | 1.86849809 |
| 143 | Protruding tongue (HP:0010808) | 1.84045751 |
| 144 | Delusions (HP:0000746) | 1.83892281 |
| 145 | Polyuria (HP:0000103) | 1.83313387 |
| 146 | Duplicated collecting system (HP:0000081) | 1.78290243 |
| 147 | Nephrocalcinosis (HP:0000121) | 1.77461968 |
| 148 | Abnormality of chromosome stability (HP:0003220) | 1.73255328 |
| 149 | Abnormal urine output (HP:0012590) | 1.72643011 |
| 150 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.71735967 |
| 151 | Purpura (HP:0000979) | 1.70978587 |
| 152 | Polydipsia (HP:0001959) | 1.70884791 |
| 153 | Abnormal drinking behavior (HP:0030082) | 1.70884791 |
| 154 | Cortical visual impairment (HP:0100704) | 1.67193919 |
| 155 | Pustule (HP:0200039) | 1.66629741 |
| 156 | Autoimmune thrombocytopenia (HP:0001973) | 1.66080897 |
| 157 | Tetany (HP:0001281) | 1.65678675 |
| 158 | Increased circulating renin level (HP:0000848) | 1.65573743 |
| 159 | Impaired platelet aggregation (HP:0003540) | 1.62623226 |
| 160 | Abnormal platelet function (HP:0011869) | 1.62623226 |
| 161 | Joint hemorrhage (HP:0005261) | 1.62355663 |
| 162 | Abnormality of the renal collecting system (HP:0004742) | 1.61619074 |
| 163 | Hypertensive crisis (HP:0100735) | 1.55277053 |
| 164 | Renal cortical cysts (HP:0000803) | 1.55063232 |
| 165 | Increased IgM level (HP:0003496) | 1.54958360 |
| 166 | Tubulointerstitial nephritis (HP:0001970) | 1.54560208 |
| 167 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.54186310 |
| 168 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.53508768 |
| 169 | Hypokalemic alkalosis (HP:0001949) | 1.52784537 |
| 170 | Abnormal spermatogenesis (HP:0008669) | 1.52079132 |
| 171 | Abnormality of renal resorption (HP:0011038) | 1.51155924 |
| 172 | Recurrent abscess formation (HP:0002722) | 1.50827851 |
| 173 | Pallor (HP:0000980) | 1.50384492 |
| 174 | Generalized hyperpigmentation (HP:0007440) | 1.49840708 |
| 175 | Small intestinal stenosis (HP:0012848) | 1.47727670 |
| 176 | Duodenal stenosis (HP:0100867) | 1.47727670 |
| 177 | Prostate neoplasm (HP:0100787) | 1.47015294 |
| 178 | Abnormality of the preputium (HP:0100587) | 1.45815903 |
| 179 | Hyperaldosteronism (HP:0000859) | 1.44823208 |
| 180 | Alkalosis (HP:0001948) | 1.44236741 |
| 181 | Global brain atrophy (HP:0002283) | 1.42844202 |
| 182 | Metabolic acidosis (HP:0001942) | 1.40962867 |
| 183 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.39632101 |
| 184 | Neutropenia (HP:0001875) | 1.37726698 |
| 185 | Meckel diverticulum (HP:0002245) | 1.37274391 |
| 186 | Clubbing of toes (HP:0100760) | 1.36730572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 5.16060507 |
| 2 | ZAK | 3.66754428 |
| 3 | TLK1 | 3.50941332 |
| 4 | MAP4K1 | 3.28396799 |
| 5 | IRAK3 | 3.22837786 |
| 6 | STK4 | 2.64458073 |
| 7 | VRK1 | 2.30451967 |
| 8 | IRAK4 | 2.19889580 |
| 9 | MATK | 2.18186848 |
| 10 | MAP3K14 | 2.15655628 |
| 11 | CSF1R | 2.06746924 |
| 12 | MAP2K3 | 1.98897654 |
| 13 | FGR | 1.95185231 |
| 14 | BRSK1 | 1.80212428 |
| 15 | INSRR | 1.77513318 |
| 16 | TAOK3 | 1.73711887 |
| 17 | CDC7 | 1.72724430 |
| 18 | ERN1 | 1.71541021 |
| 19 | STK16 | 1.68214925 |
| 20 | CSK | 1.66782603 |
| 21 | BTK | 1.65132175 |
| 22 | IKBKB | 1.61091250 |
| 23 | WNK3 | 1.55652983 |
| 24 | DDR2 | 1.55440958 |
| 25 | TNIK | 1.55081288 |
| 26 | TAOK1 | 1.53244193 |
| 27 | IKBKE | 1.49441796 |
| 28 | MAP2K7 | 1.41602504 |
| 29 | TYK2 | 1.38100703 |
| 30 | PIM1 | 1.34269128 |
| 31 | ZAP70 | 1.32692297 |
| 32 | CASK | 1.30907499 |
| 33 | CDK12 | 1.30854959 |
| 34 | NME2 | 1.30809347 |
| 35 | EIF2AK2 | 1.25837819 |
| 36 | CDC42BPA | 1.24179844 |
| 37 | BMPR2 | 1.23834685 |
| 38 | SYK | 1.20897740 |
| 39 | BMX | 1.20631373 |
| 40 | TTK | 1.18715824 |
| 41 | NEK9 | 1.17932052 |
| 42 | MAP3K3 | 1.17393009 |
| 43 | SGK2 | 1.16439436 |
| 44 | MAPK11 | 1.15698983 |
| 45 | GRK5 | 1.15357719 |
| 46 | TNK2 | 1.11814958 |
| 47 | STK3 | 1.08763602 |
| 48 | ARAF | 1.06917285 |
| 49 | JAK2 | 1.06578050 |
| 50 | HCK | 1.05614757 |
| 51 | WNK4 | 1.05487716 |
| 52 | ABL2 | 1.04773596 |
| 53 | JAK3 | 1.03871686 |
| 54 | STK24 | 1.03164016 |
| 55 | SMG1 | 1.02123181 |
| 56 | KIT | 1.01038850 |
| 57 | SIK3 | 1.00879231 |
| 58 | CHEK2 | 1.00279510 |
| 59 | FGFR4 | 0.99881037 |
| 60 | PINK1 | 0.98840222 |
| 61 | RPS6KA5 | 0.98493770 |
| 62 | DAPK2 | 0.98105886 |
| 63 | TBK1 | 0.97284356 |
| 64 | PRPF4B | 0.96700051 |
| 65 | IRAK2 | 0.95791011 |
| 66 | CHUK | 0.94955146 |
| 67 | NTRK3 | 0.94884776 |
| 68 | SGK3 | 0.94042666 |
| 69 | GRK7 | 0.93806223 |
| 70 | MARK3 | 0.93756418 |
| 71 | CLK1 | 0.91912075 |
| 72 | TEC | 0.90678113 |
| 73 | FES | 0.88707621 |
| 74 | RIPK4 | 0.84525077 |
| 75 | BLK | 0.83386529 |
| 76 | SRPK1 | 0.83264456 |
| 77 | SGK1 | 0.82973878 |
| 78 | AURKA | 0.82383242 |
| 79 | MAP3K11 | 0.81735073 |
| 80 | SGK494 | 0.81176879 |
| 81 | SGK223 | 0.81176879 |
| 82 | MAPK13 | 0.80687232 |
| 83 | JAK1 | 0.80490442 |
| 84 | BRSK2 | 0.79433652 |
| 85 | TRIB3 | 0.78820267 |
| 86 | PLK4 | 0.78814094 |
| 87 | DYRK3 | 0.78726433 |
| 88 | MOS | 0.78709196 |
| 89 | IRAK1 | 0.78099165 |
| 90 | BRAF | 0.77485183 |
| 91 | LCK | 0.76099635 |
| 92 | PDK1 | 0.75892507 |
| 93 | LYN | 0.74960783 |
| 94 | PLK1 | 0.74596109 |
| 95 | MUSK | 0.73971514 |
| 96 | PRKAA1 | 0.73954904 |
| 97 | MAP3K8 | 0.72621100 |
| 98 | GRK6 | 0.72443184 |
| 99 | PBK | 0.72403279 |
| 100 | TRPM7 | 0.71993456 |
| 101 | STK10 | 0.71505190 |
| 102 | RIPK1 | 0.70564591 |
| 103 | DAPK3 | 0.68129691 |
| 104 | AURKB | 0.67676712 |
| 105 | ADRBK2 | 0.67258175 |
| 106 | TESK2 | 0.66357326 |
| 107 | PDPK1 | 0.66130208 |
| 108 | OXSR1 | 0.66121212 |
| 109 | TAOK2 | 0.65768751 |
| 110 | MAP2K6 | 0.63508937 |
| 111 | ATR | 0.62950082 |
| 112 | HIPK2 | 0.60340578 |
| 113 | TXK | 0.59945950 |
| 114 | BRD4 | 0.58826888 |
| 115 | PKN1 | 0.57120958 |
| 116 | NEK6 | 0.55841617 |
| 117 | MAP3K5 | 0.54478262 |
| 118 | ATM | 0.53679004 |
| 119 | SIK2 | 0.53645801 |
| 120 | YES1 | 0.51700888 |
| 121 | PRKCQ | 0.51488545 |
| 122 | GRK1 | 0.50540815 |
| 123 | PRKCD | 0.50524182 |
| 124 | PIM2 | 0.49811193 |
| 125 | MAP3K12 | 0.49673029 |
| 126 | ACVR1B | 0.49669866 |
| 127 | SIK1 | 0.48560344 |
| 128 | MELK | 0.47372952 |
| 129 | NEK2 | 0.47285038 |
| 130 | MAP3K10 | 0.47024797 |
| 131 | MAPKAPK5 | 0.46842149 |
| 132 | BUB1 | 0.46489823 |
| 133 | MST4 | 0.45622790 |
| 134 | MAPK12 | 0.44737839 |
| 135 | CHEK1 | 0.44453579 |
| 136 | MAPK4 | 0.43815572 |
| 137 | MAP3K1 | 0.43573087 |
| 138 | FGFR3 | 0.43155854 |
| 139 | MKNK2 | 0.42311865 |
| 140 | ITK | 0.40584181 |
| 141 | MAP3K13 | 0.39922663 |
| 142 | TYRO3 | 0.39209633 |
| 143 | DYRK1A | 0.38284417 |
| 144 | CCNB1 | 0.37680654 |
| 145 | CDK4 | 0.37497016 |
| 146 | MAPK7 | 0.35823515 |
| 147 | RPS6KC1 | 0.31917617 |
| 148 | RPS6KL1 | 0.31917617 |
| 149 | TGFBR2 | 0.30614587 |
| 150 | PIK3CG | 0.28650425 |
| 151 | CDK6 | 0.28456700 |
| 152 | PAK1 | 0.27815263 |
| 153 | FYN | 0.27207113 |
| 154 | CAMK1D | 0.26515956 |
| 155 | MAP3K9 | 0.25838416 |
| 156 | KSR2 | 0.24169868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 8.26067411 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 4.31357047 |
| 3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.17282162 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.68950424 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.54194259 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38243310 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.31973404 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.23480925 |
| 9 | ABC transporters_Homo sapiens_hsa02010 | 2.21833472 |
| 10 | Alcoholism_Homo sapiens_hsa05034 | 2.12771295 |
| 11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.10261388 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.07768058 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.92125861 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86797053 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72565939 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.67695916 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66004509 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.56346694 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55897348 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51850208 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.49711029 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.48187679 |
| 23 | Cell cycle_Homo sapiens_hsa04110 | 1.46235130 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.45759721 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.35892894 |
| 26 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.35890148 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32881537 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31352870 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.28778082 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.26946503 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24648986 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.24518582 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.24045511 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23853347 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21704876 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18315152 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.16090774 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.15245326 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.15032774 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14135425 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14060874 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11411146 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11388390 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11356144 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 1.11293274 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07537776 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.06568308 |
| 48 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.05811992 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.04491658 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04005443 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.02247821 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.01264176 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00568205 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00320937 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 1.00272310 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99861489 |
| 57 | Mismatch repair_Homo sapiens_hsa03430 | 0.98164332 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96157308 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93019111 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91613014 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91102039 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90734907 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.90309403 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88912229 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88494687 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84388967 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81917936 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.80699324 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80533626 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80362547 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.80255149 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.77371201 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77316443 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75884371 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74509500 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74276420 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73051803 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68125130 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68121558 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68033550 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66214892 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65908935 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65858677 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64516932 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.63812229 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60712638 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60550710 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60382083 |
| 89 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60070616 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59822080 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.57090921 |
| 92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.56272192 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55482217 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54028311 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53751096 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52985089 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52869614 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.52794292 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51133291 |
| 100 | Proteasome_Homo sapiens_hsa03050 | 0.51051376 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.50911539 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49978842 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.47579499 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46724956 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46548665 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45803698 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45745398 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45670558 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45396513 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44892218 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44638116 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44444400 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44148778 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.43774409 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43638731 |
| 116 | Morphine addiction_Homo sapiens_hsa05032 | 0.42859768 |
| 117 | Taste transduction_Homo sapiens_hsa04742 | 0.41871916 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.41542927 |
| 119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.41142489 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40509674 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39848094 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39122699 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38561299 |
| 124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37483093 |
| 125 | Tuberculosis_Homo sapiens_hsa05152 | 0.35667504 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35643771 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35563992 |
| 128 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35089787 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.34773652 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.34260679 |
| 131 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33980959 |
| 132 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33539087 |
| 133 | RNA degradation_Homo sapiens_hsa03018 | 0.33218411 |
| 134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32800838 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32544788 |
| 136 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31658986 |
| 137 | RNA polymerase_Homo sapiens_hsa03020 | 0.31528132 |
| 138 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31080626 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30103807 |
| 140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29807046 |
| 141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29010263 |
| 142 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28135160 |
| 143 | Asthma_Homo sapiens_hsa05310 | 0.28098440 |
| 144 | Lysosome_Homo sapiens_hsa04142 | 0.27758475 |
| 145 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27182857 |
| 146 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26946273 |
| 147 | Mineral absorption_Homo sapiens_hsa04978 | 0.26713026 |
| 148 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24934206 |
| 149 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24320802 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23730606 |
| 151 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21539809 |
| 152 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21374066 |
| 153 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20486177 |
| 154 | Insulin resistance_Homo sapiens_hsa04931 | 0.17456180 |
| 155 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16091082 |
| 156 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14345134 |
| 157 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14255181 |
| 158 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.13227135 |
| 159 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12477668 |
| 160 | Prostate cancer_Homo sapiens_hsa05215 | 0.11637953 |

